Pilar García Alfonso (Pilar García-Alfonso, Pilar Garcia-Alfonso, P García-Alfonso)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Small Cell Lung Cancer

St Elevation Myocardial Infarction

Metastatic Colorectal Cancer

Ejection Fraction

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Journal of personalized medicine

Annals of hepato-biliary-pancreatic surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Grávalos, Fernando Pereira, Ruth Vera, Arjona-Sánchez Álvaro, Ferran Losa, Maria Isabel Ramos Bernadó, Pilar García Alfonso, Luis González Bayón, Cascales Campos Pedro Antonio, Enrique Aranda
Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Andrés Muñoz Martin, Laura Ortega, Ana Gutiérrez, Enrique Gallardo, Darío Rubio-Rodríguez, Carlos Rubio-Terrés, Blanca Morón, Pilar García Alfonso, José Manuel Soria
Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain. Journal of medical economics (2023)
Alvaro Gregorio Morales Taboada, Pablo Lozano Lominchar, Fernández-Martínez María, Pilar García Alfonso, Andrés Muñoz Martin, José Manuel Asencio
Neoadjuvant therapy impact in early pancreatic cancer: "bioborderline" vs. "non-bioborderline". Annals of hepato-biliary-pancreatic surgery 26 (4) (2022)
Joana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall, Pilar García Alfonso, David Páez, Marta Guix, Vicente Alonso, María Teresa Cano, Cristina Santos, Gema Durán, Elena Elez Fernandez, Jose Luis Manzano, Rocio Garcia-Carbonero, María Reyes Ferreiro, Ferran Losa, Estela Pineda Losada, Javier Sastre, Fernando Rivera, Beatriz Bellosillo, Josep Tabernero, Enrique Aranda, Ramón Salazar, Clara Montagut
Liquid biopsy detects early molecular response and predicts benefit to first-line chemotherapy plus cetuximab in metastatic colorectal cancer: PLATFORM-B study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Manuel Valladares-Ayerbes, Pilar García Alfonso, Jorge Muñoz Luengo, Paola Patricia Pimentel Caceres, Oscar Alfredo Castillo-Trujillo, María Del Rosario Vidal Tocino, Marta Llanos, Beatriz Llorente Ayala, Maria Luisa Limon Miron, Antonieta Salud, Luis Cirera Nogueras, Rocio Garcia-Carbonero, Maria Jose Safont, Esther Falco Ferrer, Jorge Aparicio, Maria Angeles Vicente Conesa, Carmen Guillén-Ponce, Paula Garcia-Teijido, Maria Begoña Medina Magan, Isabel Busquier, Mercedes Salgado, Ariadna Lloansí Vila, null null
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study. Cancers 14 (24) (2022)
Manuel Valladares-Ayerbes, Pilar García Alfonso, Jorge Muñoz Luengo, Paola Patricia Pimentel Caceres, Oscar Alfredo Castillo-Trujillo, María Del Rosario Vidal Tocino, Marta Llanos, Beatriz Llorente Ayala, Maria Luisa Limon Miron, Antonieta Salud, Luis Cirera Nogueras, Rocio Garcia-Carbonero, Maria Jose Safont, Esther Falco Ferrer, Jorge Aparicio, Maria Angeles Vicente Conesa, Carmen Guillén-Ponce, Paula Garcia-Teijido, Maria Begoña Medina Magan, Isabel Busquier, Mercedes Salgado, Ariadna Lloansí Vila, null null
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study. Cancers 14 (24) (2022)
Priscila Villalvazo, Belén Marzal-Alfaro, Pilar García Alfonso, José Luis Revuelta-Herrero, Fabienne Thomas, Sara López-Tarruella, Xandra García, Aitana Calvo, Malika Yakoubi, Sara Salvador-Martín, Flora López-López, Iker Aguilar, María Sanjurjo-Sáez, Miguel Martin, Luis Andrés López-Fernández
DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach. Journal of personalized medicine 11 (8) (2021)
Pilar García Alfonso, Eduardo Díaz-Rubio, Albert Abad, Alfredo Carrato, Bartomeu Massutí, María José Ortiz-Morales, José Luis Manzano Mozo, Andrés Muñoz, Gema Durán, Javier Sastre, María José Safont, Reyes Ferreiro, Fernando Rivera, Encarnación González, Manuel Valladares-Ayerbes, Cristina Grávalos, Vicente Alonso-Orduña, José María Viéitez, Alfonso Yubero, Enrique Aranda, null null
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis. Drugs & aging 38 (3) (2021)
Pilar García Alfonso, Miriam Saiz-Rodríguez, R Mondéjar, J Salazar, D Páez, Alberto M Borobia, M J Safont, I García-García, R Colomer, X García-González, M J Herrero, L A López-Fernández, Francisco Abad-Santos
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
Pilar García Alfonso, Andrés Muñoz Martin, Jerónimo Jiménez-Castro, Paula Jiménez-Fonseca, Carles Pericay, Federico Longo-Muñoz, Carmen Reyna-Fortes, Guillem Argilés-Martínez, Beatriz Gonzalez-Astorga, María José Gómez-Reina, Ana Ruiz-Casado, Nuria Rodríguez-Salas, Rafael López-López, Alberto Carmona-Bayonas, Verónica Conde-Herrero, Enrique Aranda, null On Behalf Of The Ros Study Group
Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study. Cancers 13 (18) (2021)
Pilar García Alfonso, Andrés Jesús Muñoz Martín, Laura Ortega Morán, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Montserrat Blanco Codesido, Pilar Aitana Calvo Ferrandiz, Silvina Grasso Cicala
Oral drugs in the treatment of metastatic colorectal cancer. Therapeutic advances in medical oncology 13 (2021)
Elisa Conde, Julie Earl, Lorena Crespo-Toro, Carolina Blanco-Agudo, Edurne Ramos-Muñoz, E Macarena Rodríguez-Serrano, Jose Carlos Martínez Ávila, Laura Salinas-Muñoz, Silvia Serrano-Huertas, Reyes Ferreiro, Mercedes Rodriguez-Garrote, Bruno Sainz, Bartomeu Massuti, Pilar García Alfonso, Manuel Benavides, Enrique Aranda, María Laura García-Bermejo, Alfredo Carrato
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study. Cancers 13 (7) (2021)
Pilar García Alfonso, R García-Carbonero, J García-Foncillas, P Pérez-Segura, R Salazar, R Vera, S Ramón Y Cajal, J Hernández-Losa, S Landolfi, E Musulén, M Cuatrecasas, S Navarro
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (11) (2020)
Pilar García Alfonso, G García-González, I Gallego, M I Peligros, L Ortega, G Torres Pérez-Solero, C Sandoval, A Muñoz Martin, M Blanco Codesido, A Calvo Ferrándiz, M Martin
Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (1) (2020)